Commercial insurance delays direct-acting antiviral treatment for hepatitis C kidney transplantation into uninfected recipients.
Torabi J, Rocca JP, Ajaimy M, Melvin J, Campbell A, Akalin E, Liriano LE, Azzi Y, Pynadath C, Greenstein SM, Le M, Goldstein DY, Fox AS, Carrero J, Weiss JM, Powell T, Racine AD, Reinus JF, Kinkhabwala MM, Graham JA.
Torabi J, et al. Among authors: greenstein sm.
Transpl Infect Dis. 2021 Feb;23(1):e13449. doi: 10.1111/tid.13449. Epub 2020 Sep 3.
Transpl Infect Dis. 2021.
PMID: 32810315